Automated Method Development With UPLC and Fusion Software A Quality by Design-based Tool Jean-Michel Plankeele May Waters Corporation 1
|
|
- Evelyn Jacobs
- 5 years ago
- Views:
Transcription
1 Automated Method Development With UPLC and Fusion Software A Quality by Design-based Tool Jean-Michel Plankeele May Waters Corporation 1
2 Agenda LC method development and Quality-by-Design guidelines Definition of key words: QbD, DOE, Design Space Waters consistent approach for efficient method development FusionMD for method development How it works, what it does Summary & conclusions 2012 Waters Corporation 2
3 Quality By Design Published Guidelines QbD approach has been there since decades in all types of industry More recently implemented in pharmaceutical area (early 2000) Guidelines are published by ICH* Everything about QbD, design of experiment can be found in ICH Q8 (R2) QbD, DoE, design space, graphical tools Additional details in ICH Q9 & Q10 *ICH: International Conference on Harmonisation 2012 Waters Corporation 3
4 Some Definitions What Is Quality By Design? Quality by Design: A systematic approach to development that begins with predefined objectives and emphasizes product and process understanding and process control, based on sound science and quality risk management ICH Q8(R2) Guidelines QbD is a systematic approach to development No speculation or a priori statements about results that begins with predefined objectives Defining criteria (response factors) to be used to measure the quality of the method sound science and quality risk management Statistical treatment of data to provide quantitative values to goals and limits of response factors QbD approach is implemented with an experimental design 2012 Waters Corporation 4
5 ICH Q8 (R2) guidelines for Design Of Experiment (DoE) Formal Experimental Design: A structured, organized method for determining the relationship between factors affecting a process and the output of that process. Also known as Design of Experiments. ICH Q8(R2) Guidelines A structured and organized method of gathering empirical knowledge DoE are represented as a multi-dimensional spaces (matrix) Selectivity parameters (study variables) are the dimensions of this space Z (Organic Solvent) Best method Number of experiments is optimized using an appropriate study design (full factorial design & partial factorial design) X (ph) Y (Gradient Time) 2012 Waters Corporation 5
6 What Is a Design? Full Factorial, Partial With a full factorial design, all elements (experiments) of the matrix are sampled In an incomplete factorial design the multidimensional space is sampled evenly and efficiently Factor levels are chosen randomly and then balanced to achieve uniform sampling Three variable full factorial design Three variable partial factorial design 2012 Waters Corporation 6
7 ICH Q8 (R2) guidelines Design Space Design Space: the multidimensional combination and interaction of input variables (e.g., material attributes) and process parameters that have been demonstrated to provide assurance of quality. Working within the design space is not considered as a change ICH Q8(R2) Guidelines Around the best method, there is a space where the method achieves the predifined objectives This is the area of robustness Z optimum Z Operating Space Each method (combination of parameters) within the design space meets the requirements Working within the design space is not considered as a change No need for revalidation within the design space Y optimum Y (Gradient Time) X (ph) X optimum 2012 Waters Corporation 7
8 ICH Q8 (R2) Recommandations For Depiction Of Interactions And Design Space Response graphs: 3 D plots for viewing effects (linear effects, combined effects, interactions ) 3 D plots for evaluating the performances Contour plots (or 2 D plots) for evaluating the robustness 2012 Waters Corporation 8
9 How Does It Translate When Developping LC Methods? Quality by design Chromatographers must consider all selectivity parameters The impact of parameters (range/effect) must be evaluated Chromatographers must work with preset objectives o Cleaning validation o Impurity profiling o Quality control Speed Resolution Speed, specificity Experiment design, design of experiment (DoE) Definition of experimental region, selection of study variables with their ranges Primary selectivity parameters Stationnary phase, ph & solvent Secondary selectivity parameters Temperature, flow rate, slope, gradient time, 2012 Waters Corporation 10
10 Agenda LC method development and Quality-by-Design guidelines Definition of key words QbD DOE, Design Space FusionMD for method development What is it, What it does, how it works Summary, conclusions 2012 Waters Corporation 11
11 What Is Fusion - What It Does Fusion works in cooperation with Empower I, II & III From workstation to network Fusion supports all UPLC configurations ACQUITY UPLC and H-CLASS All optical detectors Solvent switching valves (external/uplc or internal/ssv) Column managers (temperature control and column switching) Fusion supports all Empower controlled configurations Alliance, Automatically builds methods, method sets and sample sets 2012 Waters Corporation 12
12 Fusion Alignment With [Q b D] Approach [1] Define Experimental Region Select study variables Define study ranges Screening/scouting of all selectivity parameters Supports RP, NP, IEX, SEC, HILIC, Controls all UPLC configurations All options (detectors, valves, ovens) [2] Develop Knowledge Space Applies the DoE approach Structured, optimized set of experiments Conduct experimental design Analyze results and study variable effects Full factorial and partial factorial designs Automatically creates and exports all methods [3] Establish Design Space Builds the models of variable effects Finds the best method Define optimum conditions Define robust operating space Incorporates robustness modeling in the MD process 2012 Waters Corporation 13
13 Fusion Workflow In A Few Simple Steps 1. User selects the experimental parameters (study factors or study variables): Columns, temp, solvents, ph, slope, Quality by Design: A systematic approach to development that begins with predefined objectives and emphasizes product and process understanding and process control, based on sound science and quality risk management ICH Q8(R2) Guidelines 2012 Waters Corporation 14
14 Step 1 Define The Variables And Their Ranges Flow rate Gradient shape (time, slope, hold, wash, ) Gradient curve Column temp. ph Buffer strength Organic solvent Column type Injection volume Wavelength 2012 Waters Corporation 15
15 Fusion Workflow In A Few Simple Steps 1. User selects the experimental parameters (study factors or study variables): Columns, temp, solvents, ph, slope, 2. Fusion generates all required methods and creates the experiment design in Empower Formal Experimental Design: A structured, organized method for determining the relationship between factors affecting a process and the output of that process. Also known as Design of Experiments. ICH Q8(R2) Guidelines 2012 Waters Corporation 16
16 Step 2 Create & Export The Design To Empower Fusion automatically selects the most statistically appropriate design type and generates the experiment Minimizes the number of runs Creates instrument methods and method sets within Empower Automatically reconstructs experimental design within Empower The newly created sample set can be edited/customised 2012 Waters Corporation 17
17 Fusion Workflow In A Few Simple Steps 1. User selects the experimental parameters (study factors or study variables): Columns, temp, solvents, ph, slope, 2. Fusion generates all required methods and creates the experiment design in Empower 3. The methods defined above are run on the system Few hours with UPLC vs days with HPLC 2012 Waters Corporation 18
18 Fusion Workflow In A Few Simple Steps 1. User selects the experimental parameters (study factors or study variables): Columns, temp, solvents, ph, slope, 2. Fusion generates all required methods and creates the experiment design in Empower 3. The methods defined above are run on the system 4. Fusion imports results from Empower and builds the models 2012 Waters Corporation 19
19 Step 4 Process Results 2 Develop Knowledge Space* Conduct formal experimental design Analyze results, build equations Run and Process KNOWLEDGE SPACE The information and knowledge gained from pharmaceutical development studies and manufacturing experience to support the establishment of the design space, specifications, and manufacturing controls. [ ICHQ8(R1)] R s = β o + β 1 (X 1 ) + β 11 (X 1 ) 2 + β 2 (X 2 ) + β 22 (X 2 ) 2 + β 12 (X 1 *X 2 ) Linear Effect (main effects term) Curvature Effect (simple curvilinear effects) Interaction Effect (two-way effects) 2012 Waters Corporation 20
20 Fusion Workflow In A Few Simple Steps 1. User selects the experimental parameters (study factors or study variables): Columns, Temp, solvents, ph, slope, 2. Fusion generates all required methods and creates the experiment design in Empower 3. The methods defined above are run on the system 4. Fusion imports results from Empower and builds the models 5. Fusion combines the mathematical models to predict the optimum method 2012 Waters Corporation 21
21 Step 5 Automated Numerical Search for Optimum User enters chromatographic performance goals: Any calculated result can be selected Result fields: No. of peaks, No. of peaks > n%, Peak fields: Rs of max peak, RT of last peak, purity index of max peak, Custom fields can also be selected Fusion MD identifies study parameters of best method performance 2012 Waters Corporation 22
22 Step 5 Numerical Solution Search, Best Conditions Fusion MD identifies study parameters of best method performance 2012 Waters Corporation 23
23 Graphical Tools Visualize factor effects with overlay graphs Define performance goals (No. of peaks > 8) Visualize effects Shaded region indicates Final % and Gradient Time combinations that do not meet performance requirements Waters Corporation 24
24 Add effects to build the Design Space Define performance goals (No. of peaks > 8, RT < 3 min) Visualize effects 2 performance goals Shaded regions indicate Final % and Gradient Time combinations that do not meet performance requirements Waters Corporation 25
25 Combine All Performance Goals Establish the Design Space Design Space Mean Performance Operating space = + Robustness 2012 Waters Corporation 26
26 Next Phase Of Method Development Option 1: Confirm optimised settings Run the sample with predicted settings Automatically built methods and sample set Method is ready to be validated Option 2: Optimise these predicted settings Select best column, best solvent Fine tune secondary parameters o Slope, flow rate, column temperature 2012 Waters Corporation 27
27 Summary & Conclusions FusionMD is a tool for developing LC methods according to Quality-by-Design (QbD) guidelines Automates the entire process of method development Saves time by determining the minimum number of experiments needed for valid results Provides tools to vizualise the impact of chromatographic parameters Integrates robustness during development FusionMD is a part of a System Solution Empower UPLC chemistry UPLC hardware 2012 Waters Corporation 28
28 Need More Information? Waters Corporation 29
Automated QbD-Based Method Development and Validation of Oxidative Degraded Atorvastatin
Automated QbD-Based Method Development and Validation of Oxidative Degraded Atorvastatin Application Note Pharmaceutical QA/QC Authors Vinayak AK and Syed Salman Lateef Agilent Technologies Inc, Bangalore,
More informationFusion Analytical Method Validation
Fusion QbD Software Platform Fusion Analytical Method Validation The Only Software That Has It All! 100% aligned with FDA/ICH Quality by Design (QbD) guidances! Can be used for LC and Non-LC methods (e.g.
More informationQuality-by-Design-Based Method Development Using an Agilent 1290 Infinity II LC
Quality-by-Design-Based Method Development Using an Agilent 129 Infinity II LC An Efficient Method Development Workflow Combined with ISET-mediated Method Transfer Under Waters Empower 3 CDS Control Application
More informationAdvancedTools in HPLC methoddevelopment
AdvancedTools in HPLC methoddevelopment Remco Stol, Enrico Martina and Jeffrey Vos Analytical Sciences Chemistry, Quality Unit API/BT NL FHI symposium, Houten, 22 april 2010 What does the customer want?
More informationFusion Analytical Method Validation
Fusion QbD Software System Fusion Analytical Method Validation The Only Software That Has It All! 100% aligned with FDA/ICH Quality by Design (QbD) guidances! Can be used for LC and Non-LC methods (e.g.
More informationDeveloping Robust and Efficient IEX Methods for Charge Variant Analysis of Biotherapeutics Using ACQUITY UPLC H-Class System and Auto Blend Plus
Developing Robust and Efficient IEX Methods for Charge Variant Analysis of Biotherapeutics Using ACQUITY UPLC H-Class System and Auto Blend Plus Robert Birdsall, Thomas Wheat, and Weibin Chen Waters Corporation,
More informationPeptide Mapping: A Quality by Design (QbD) Approach
Peptide Mapping: A Quality by Design (QbD) Approach Application Note Bio-Pharmaceutical Authors Sreelakshmy Menon and Suresh babu C.V. Agilent Technologies, Inc. Richard Verseput S-Matrix Corporation Abstract
More informationPAT and UPLC Round Table Introducing PATROL Systems David Lascoux Jean-Michel Plankeele Biopharma LC Meeting Eschborn, October 17th
PAT and UPLC Round Table Introducing PATROL Systems David Lascoux Jean-Michel Plankeele Biopharma LC Meeting Eschborn, October 17th 2012 Waters Corporation 1 What Is PAT? What Are the PATROL Systems For?
More informationFUTURE-PROOF SOLUTIONS FOR REGULATED LABORATORIES IN THE FACE OF CHANGING USP <621> GUIDELINES
FUTURE-PROOF SOLUTIONS FOR REGULATED LABORATORIES IN THE FACE OF CHANGING USP GUIDELINES How to use UPLC technology within allowable adjustments to improve QC laboratory throughput For many in the
More informationA Quality-by-Design Approach to the Rapid Development of Robust HPLC Methods
A Quality-by-Design Approach to the Rapid Development of Robust HPLC Methods Introduction Chromatographic analytical method development is currently a time consuming process usually done by trial and error.
More informationSean M. McCarthy and Martin Gilar Waters Corporation, Milford, MA, U.S. INTRODUCTION EXPERIMENTAL RESULTS AND DISCUSSION
UPLC Separation of DNA Duplexes Sean M. McCarthy and Martin Gilar Waters Corporation, Milford, MA, U.S. INTRODUCTION Over the past 2 years there has been a considerable amount of effort focused on the
More informationACQUITY Arc VERSATILITY WITHOUT COMPROMISE
ACQUITY Arc VERSATILITY WITHOUT COMPROMISE BUILT UPON A FOUNDATION OF RELIABILITY With the ACQUITY Arc System, analytical scientists can experience true plug-and-play method compatibility for HPLC and
More informationH-Class & H-Class Bio AutoBlend and AutoBlend plus. Jean-Michel Plankeele May Waters Corporation 1
H-Class & H-Class Bio AutoBlend and AutoBlend plus Jean-Michel Plankeele May 2012 2012 Waters Corporation 1 UPLC H-Class Introduction in 2010 What Were The Requests? More flexibility? More solvent capability
More informationDeveloping Quantitative UPLC Assays with UV
Developing Quantitative UPLC Assays with UV Detection for Antibodies & Other Proteins Steve Taylor 2011 Waters Corporation 1 Outline UPLC technology for RP protein separations Method development parameters
More informationMass Detection for the Chromatographer Waters ACQUITY QDa Detector
Mass Detection for the Chromatographer Waters ACQUITY QDa Detector Warren B Potts III Senior Director Americas Marketing warren_potts@waters.com 2017 Waters Corporation 1 Agenda Overview of technology
More informationThe concept of quality by design
B i o P r o c e s s TECHNICAL Implementing Quality By Design in Analytical Development A Case Study on the Development of an Anion-Exchange HPLC Method Quan Yuan, Weijun Li, and Lisa Regan The concept
More informationImpurity Control in the European Pharmacopoeia
Impurity Control in the European Pharmacopoeia Training Session Zagreb, Croatia, 24-25 May, 2018 Dr Ulrich Rose Head of Division European Pharmacopoeia Department, EDQM Agenda Which impurities are controlled?
More informationGenerating Automated and Efficient LC/MS Peptide Mapping Results with the Biopharmaceutical Platform Solution with UNIFI
with the Biopharmaceutical Platform Solution with UNIFI Vera B. Ivleva, Ying Qing Yu, Scott Berger, and Weibin Chen Waters Corporation, Milford, MA, USA A P P L I C AT ION B E N E F I T S The ability to
More informationOnline UPLC Method for the Support of Cleaning Validation and the Routine Monitoring of Cleaning Procedures
Online UPLC Method for the Support of Cleaning Validation and the Routine Monitoring of Cleaning Procedures Tanya Tollifson Waters Corporation, Milford, MA, USA APPLICATION BENEFITS Online cleaning wash
More informationSimplifying Methods Transfer: Novel Tools for Replicating Your Established Methods on an ACQUITY Arc System
Simplifying Methods Transfer: Novel Tools for Replicating Your Established Methods on an ACQUITY Arc System Paula Hong, Richard Andrews, Peyton C. Beals, and Patricia R. McConville Waters Corporation,
More informationSeparation Science Built for Biopharma
Separation Science Built for Biopharma Pharma & Biopharma Tours 2016 The world leader in serving science Overview 1. Evolution of UHPLC built for biopharma Meet the family 2. What makes Vanquish different?
More informationAutomating HPLC and GC Analytical Method Validation Fusion AE Software Program White Paper
Automating HPLC and GC Analytical Method Validation Fusion AE Software Program White Paper S-Matrix Corporation 1594 Myrtle Avenue Eureka, CA 95501, USA www.smatrix.com Introduction Chromatographic analytical
More informationTechnical Overview. Author. Abstract. Edgar Naegele Agilent Technologies, Inc. Waldbronn, Germany
New Features of the Agilent Method Scouting Wizard for Automated Method Development of Complex Samples Analysis of Large Data Sets by Method Scouting Reports and Automated Adjustment of Flow Rates and
More informationHPLC to UPLC Method Migration: An Overview of Key Considerations and Available Tools
HPLC to UPLC Method Migration: An Overview of Key Considerations and Available Tools Dr. Michael Swartz, Ph. D. Principal Consulting Scientist Worldwide Pharmaceutical Business Operations Waters Corporation
More informationDo you Have Confidence in your Data? Considerations for Minimising Out-of-Specification (OOS) Results in Pharmaceutical QC
Do you Have Confidence in your Data? Considerations for Minimising Out-of-Specification (OOS) Results in Pharmaceutical QC Waters Pharma & Biopharmaceutical LC-MS Forum Eschborn, Wednesday June 20 th 2018
More informationAutomating HPLC and GC Analytical Method Validation Fusion AE Software Program White Paper
Automating HPLC and GC Analytical Method Validation Fusion AE Software Program White Paper Varian, Inc. 2700 Mitchell Drive Walnut Creek, California 94598, USA www.varianinc.com Introduction Chromatographic
More information2012 Waters Corporation 1
UPLC User meeeting April 2012 Principles and Practices for SEC, IEX for Intact Protein Analysis by UPLC anders_feldthus@waters.com 2012 Waters Corporation 1 Agenda Ion-Exchange Chromatography Theory and
More informationCase Study on Application of Analytical Life Cycle Management and Risk Management
Case Study on Application of Analytical Life Cycle Management and Risk Management Jianmei, Ph.D. Genzyme, a Sanofi Company AAPS 2015 Dione Pompe disease Brazil www.genzyme.com Outline Introduction of Concepts
More informationFusion AE. Analytical Method Development And Method Validation
Analytical Method Development And Method Validation Automated Experimentation Chemometric platform for analytical method development and validation. Auto-control of instrument parameters, external solvent
More informationCHAPTERS 1, 2 and 3 CHAPTER-4 CHAPTER-5,
319 Presently in the pharmaceutical industry, drug analysis plays a vital role in deciding the quality and potency of the drug. The selection of analytical method used to quantify the drugs and impurities
More informationAgilent 1290 Infinity Binary LC System with ISET Emulation of a Waters Alliance 2695 LC Applying Concave, Convex, and Linear Gradients
Agilent 129 Infinity Binary LC System with ISET Emulation of a Waters Alliance 269 LC Applying Concave, Convex, and Linear Gradients Technical Overview Author A.G. Huesgen Agilent Technologies Inc. Waldbronn,
More informationProteins. Patrick Boyce Biopharmaceutical Marketing Manager Waters Corporation 1
Routine Characterization of mabs and Other Proteins Patrick Boyce Biopharmaceutical Marketing Manager Europe and India 2011 Waters Corporation 1 Agenda Why? What scientific challenges? Technology Example
More informationExploring Extra Sensitivity Using ionkey/ms with the Xevo G2-XS Q-Tof HRMS for Small Molecule Pharmaceutical Analysis in Human Plasma
Exploring Extra Sensitivity Using ionkey/ms with the Xevo G2-XS Q-Tof HRMS for Small Molecule Pharmaceutical Analysis in Human Plasma Yun Wang Alelyunas, Mark D. Wrona, Jim Murphy, Angela Doneanu, Gregory
More informationAgilent 1290 Infinity II 2D-LC Solution Biopharmaceutical Polymer Analysis. WCBP Jan 2017 Washington, DC
Agilent 1290 Infinity II 2D-LC Solution Biopharmaceutical Polymer Analysis WCBP Jan 2017 Washington, DC 1 Overview Resolving power and how to measure it Why two-dimensional LC? Setup of a 2D-LC System
More informationApplication Note LCMS-87 Automated Acquisition and Analysis of Data for Monitoring Protein Conjugation by LC-MS Using BioPharma Compass
Application Note LCMS-87 Automated Acquisition and Analysis of Data for Monitoring Protein Conjugation by LC-MS Using BioPharma Compass Abstract Here we describe the development and use of an automated
More information[ APPLICATION NOTE ] APPLICATION BENEFITS INTRODUCTION WATERS SOLUTIONS KEYWORDS
Quantitative Method for the Determination of Potentially Mutagenic Impurities of Ondansetron Using UPC 2 Coupled with a Xevo TQ-S micro Jennifer Simeone, Paula Hong, and Patricia R. McConville Waters Corporation,
More informationAutomated Purification Software for Agilent OpenLAB CDS
Automated Purification Software for Agilent OpenLAB CDS Data Sheet Introduction Agilent 1260 Infinity LC and LC/MS purification systems offer flexible and easy to use solutions for purification of microgram
More informationACQUITY UPLC. I-Class PLUS WHAT SEPARATES YOU FROM EVERYONE ELSE
ACQUITY UPLC I-Class PLUS WHAT SEPARATES YOU FROM EVERYONE ELSE COMPLEX CHALLENGES SOLVED Looking for answers to the most complex scientific challenges is what you do. Your research could lead to ground-breaking
More informationTechnical Overview. Author. Abstract. A.G.Huesgen Agilent Technologies, Inc. Waldbronn, Germany
Transferring methods to the Agilent 129 Infinity LC System using Intelligent System Emulation Technology (ISET) Analysis of paracetamol and its impurities Technical Overview Author A.G.Huesgen Agilent
More informationApplication Note. Author. Abstract. Pharmaceuticals. Detlef Wilhelm ANATOX GmbH & Co. KG. Fuerstenwalde, Germany mau
Development, validation, and comparison of an HPLC method to analyze paracetamol and related impurities according to the European Pharmacopoeia (EP) and USP using the Agilent 1120 Compact LC and the Agilent
More informationAutomatic Combination of Orthogonal Separation Modes for Multiple Components in Mixtures
Automatic Combination of Orthogonal Separation Modes for Multiple Components in Mixtures Thomas E. Wheat, Amanda B. Dlugasch, and Patricia R. McConville Waters Corporation IFPAC January 26, 2016 2016 Waters
More informationAltus UPLC IT S ALL ABOUT PEAK PERFORMANCE
Altus UPLC IT S ALL ABOUT PEAK PERFORMANCE CHROMATOGRAPHY FOR THE WORK YOU DO CHROMATOGRAPHY AT A WHOLE NEW LEVEL OF CONFIDENCE Altus UPLC Food The Altus UPLC system and Empower 3 CDS help ensure that
More informationA Simple Rapid and Sensitive Method Development for Quantification of Quetiapine Fumarate in Bulk and Dosage Forms Using RP-HPLC
Human Journals Research Article February 2018 Vol.:11, Issue:3 All rights are reserved by Priyanka Teepoju et al. A Simple Rapid and Sensitive Method Development for Quantification of Quetiapine Fumarate
More informationAutomated Scouting of Stationary and Mobile Phases Using the Agilent 1290 Infinity II Method Development Solution
Automated Scouting of Stationary and Mobile Phases Using the Agilent 129 Infinity II Method Development Solution Technical Overview Authors Edgar Naegele and Sonja Schneider Agilent Technologies, Inc.
More informationThe Agilent StreamSelect LC/MS Solution: Increasing the Throughput of a Triple Quadrupole Mass Spectrometer
The Agilent StreamSelect LC/MS Solution: Increasing the Throughput of a Triple Quadrupole Mass Spectrometer Technical Overview Introduction Liquid chromatography triple quadrupole mass spectrometry (LC/MS/MS)
More informationFusionChrom. Analytical Method Development And Method Validation
Analytical Method Development And Method Validation Automated Experimentation Chemometric platform for analytical method validation. Auto-control of instrument parameters, external solvent selection valves,
More informationeasy. HPLC has never been so Agilent 1120 Compact LC Our measure is your success.
easy. HPLC has never been so Agilent 1120 Compact LC Our measure is your success. Introducing the Agilent 1120 Compact LC Simply a better value. Is your lab looking for better, more reproducible results
More informationMaximizing Chromatographic Resolution of Peptide Maps using UPLC with Tandem Columns
Maximizing Chromatographic Resolution of Peptide Maps using UPLC with Tandem Columns Hongwei Xie, Martin Gilar, and Jeff Mazzeo Waters Corporation, Milford, MA U.S. APPLICATION BENEFITS The ACQUITY UPLC
More information10. Validated Normal Phase HPLC Method for the Determination. Fulvestrant is primarily used in the treatment of hormone receptor
229 10. Validated Normal Phase HPLC Method for the Determination of Fulvestrant in Pharmaceutical Dosage Forms 10.1 Introduction Fulvestrant is primarily used in the treatment of hormone receptor positive
More informationHigh-resolution Analysis of Charge Heterogeneity in Monoclonal Antibodies Using ph-gradient Cation Exchange Chromatography
High-resolution Analysis of Charge Heterogeneity in Monoclonal Antibodies Using ph-gradient Cation Exchange Chromatography Agilent 1260 Infinity Bio-inert Quaternary LC System with Agilent Bio Columns
More informationMethod Development Considerations for Reversed-Phase Protein Separations
Method Development Considerations for Reversed-Phase Protein Separations Hillary B. Hewitson, Thomas E. Wheat, Paula Hong, Kenneth J. Fountain APPLICATION BENEFITS n The BEH00 C 4 chemistry is available
More informationQualification of UPLC system IRequest UPLC Community Tips & tricks Waters Corporation 1
News from service 22.05.2012 Qualification of UPLC system IRequest UPLC Community Tips & tricks 2007 Waters Corporation 1 2007 Waters Corporation 2 System QT What is SystemsQT? Key benefits How is it installed?
More information9/2/2014. USP Monograph Modernization. Todays topics. USP basic. Todays topics. - USP basic. - USP publications. - USP monograph modernization
USP Monograph Modernization Procedure Review and Development Donald Min 2 USP basic Since USP's founding in 1820, our operations have grown exponentially: from 11 volunteers collaborating from their respective
More informationPerformance characteristics of the 1260 Infinity Quaternary LC system
Performance characteristics of the 1260 Infinity Quaternary LC system The new standard in HPLC Technical Overview Introduction The Agilent 1260 Infinity LC system consists of modular units that operate
More informationAgilent Automated Card Extraction Dried Blood Spot LC/MS System
Agilent Automated Card Extraction Dried Blood Spot LC/MS System Quick Start Guide What is the AACE DBS LC/MS System? 2 System Overview 3 Operational Overview 4 Method Development 5 Using the AACE DBS LC/MS
More informationPLC Purification Systems
PLC Purification Systems Preparative HPLC, flash, and CPC in one compact purification system LARGE CAPACITY HIGH VERSATILITY COMPACT FOOTPRINT One system for many columns All the features you need in one
More informationAgilent 1260 Infinity II Prime LC ACHIEVE CONVENIENCE EVERY DAY IN EVERY WAY
1260 Agilent 1260 Infinity II Prime LC ACHIEVE CONVENIENCE EVERY DAY IN EVERY WAY AGILENT 1260 INFINITY II PRIME LC ACHIEVE CONVENIENCE AND EFFICIENCY EVERY DAY IN EVERY WAY The Agilent 1260 Infinity II
More informationDEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR ASSAY DETERMINATION OF ISOSULFAN BLUE BY LIQUID CHROMATOGRAPHY
DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR ASSAY DETERMINATION OF ISOSULFAN BLUE BY LIQUID CHROMATOGRAPHY KISHORKUMAR L.MULE 1 Department of Chemistry, Shri Jagdish Prasad Jhabarmal Tibrewala
More informationValidation of Analytical Methods used for the Characterization, Physicochemical and Functional Analysis and of Biopharmaceuticals.
Validation of Analytical Methods used for the Characterization, Physicochemical and Functional Analysis and of Biopharmaceuticals. 1 Analytical Method Validation: 1..1 Philosophy: Method validation is
More informationAnalytical Procedures and Methods Validation for Drugs and Biologics
Analytical Procedures and Methods Validation for Drugs and Biologics Lucinda (Cindy) Buhse, Ph. D. Acting Director, Office of Testing and Research Office of Pharmaceutical Science CDER, FDA CHPA Quality
More informationACQUITY Arc TM System
ACQUITY Arc TM System Introducing the Newest Member of the Waters LC Portfolio 2015 Waters Corporation 1 Adopting Modern LC Technology in a Global Economy Highly competitive, regulated business environment
More informationFast and Comprehensive 2-Dimensional Liquid Chromatography of Block Copolymers through Temperature Gradient Driven Trapping
Fast and Comprehensive 2-Dimensional Liquid Chromatography of Block Copolymers through Temperature Gradient Driven Trapping International Symposium on GPC/SEC and related techniques Bastiaan Staal & Joshua
More informationQuality by Design Considerations for Analytical Procedures and Process Control
Quality by Design Considerations for Analytical Procedures and Process Control Moheb M. Nasr, Ph.D. ONDQA/CDER/FDA IFPAC 2009 Baltimore, MD January 26, 2009 1 Outline Background on FDA Initiatives and
More informationPurification Workflow Management
Ronan Cleary and Paul Lefebvre Waters Corporation, Milford, MA, USA INTRODUCTION A standard requirement for drug discovery screening of synthetic libraries is that the test compounds must have a minimum
More informationTechniques for Improving the Efficiency of Large Volume Loading in Preparative Liquid Chromatography
Techniques for Improving the Efficiency of Large Volume Loading in Preparative Liquid Chromatography Jo-Ann M. Jablonski, Andrew J. Aubin, and Wendy Harrop Waters Corporation, Milford, MA, USA APPLICATION
More informationValidation of a Dual Wavelength Size Exclusion HPLC Method with Improved Sensitivity to Detect Aggregates of a Monoclonal Antibody Biotherapeutic
Validation of a Dual Wavelength Size Exclusion HPLC Method with Improved Sensitivity to Detect Aggregates of a Monoclonal Antibody Biotherapeutic By J. Tompkins1, T. Spurgeon 1, R. Tobias 1, J. Anders1,
More informationMartin Gilar Waters Corporation, Milford, MA, U.S. Origins of synthetic oligonucleotides impurities. Lab-scale isolation options
LIGNUCLETIDE SEPARATIN TECHNLGY: SYNTHESIS CHALLENGES AND HPLC ISLATIN PTINS Martin Gilar Waters Corporation, Milford, MA, U.S. INTRDUCTIN rigins of synthetic oligonucleotides impurities Use of synthetic
More informationALLIANCE SYSTEM FOR CARBAMATE ANALYSIS
ALLIANCE SYSTEM FOR CARBAMATE ANALYSIS Are you concerned with any of these issues? Is your method capable of meeting the precision and accuracy requirements for carbamates mandated by the Environmental
More informationControlling Agilent 1200 Series Rapid Resolution LC systems through Waters Empower chromatography data software. Technical Overview.
Controlling Agilent 1200 Series Rapid Resolution LC systems through Waters Empower chromatography data software Technical Overview Abstract The Waters Empower 2 chromatography data software with ICS 1.05
More informationUNIFI: an innovative enabling platform Ken Eglinton Nordic User Training, September 2013
UNIFI: an innovative enabling platform Ken Eglinton Nordic User Training, September 2013 2013 Waters Corporation 1 Waters Laboratory Informatics Product Portfolio MassLynx Mass Spectrometry Software NuGenesis
More informationQuick Manual to the Waters UPLC System
1 Quick Manual to the Waters UPLC System 1. Application of Chiral HPLC Columns Warning! The HPLC columns are destroyed if the pressure overrides 2000 psi. The highest pressure applied for routine analysis
More informationAgilent 1290 Infinity II LC SET NEW BENCHMARKS IN EFFICIENCY WITH THE NEXT GENERATION OF UHPLC
1290 Agilent 1290 Infinity II LC SET NEW BENCHMARKS IN EFFICIENCY WITH THE NEXT GENERATION OF UHPLC AGILENT 1290 INFINITY II LC NEW BENCHMARKS IN EFFICIENCY The Agilent 1290 Infinity II LC embodies the
More informationPreparative HPLC: Factors and Parameters that Directly Affect Recovery of Collected Fractions
Preparative HPLC: Factors and Parameters that Directly Affect Recovery of Collected Fractions Gary Scharrer and Joan Stevens, Ph.D. Gilson, Inc Middleton, WI www.gilson.com Abstract Purification of synthetic,
More information[ APPLICATION NOTE ] Developing Analytical Chromatographic Methods for Pharmaceutical Stability Investigations APPLICATION BENEFITS INTRODUCTION
Developing Analytical Chromatographic Methods for Pharmaceutical Stability Investigations Thomas Swann Waters Corporation, Milford, MA, USA APPLICATION BENEFITS Understand factors, responses, response
More informationEnhanced Analytical Development for Complex Antibody Formats. Markus Wild, F. Hoffmann - La Roche Ltd., Switzerland
Enhanced Analytical Development for Complex Antibody Formats Markus Wild, F. Hoffmann - La Roche Ltd., Switzerland Outline Introduction Tools for Enhanced Method Development Case Study 1 Case Study 2 More
More informationChromera Speciation Software The Right Tool for the Right Answer. ICP-Mass Spectrometry. Key Benefits
P r o d u c t N o t e ICP-Mass Spectrometry Key Benefits Fully-integrated system with seamless operation Proven multielement analytical methodologies Efficient workflow tools Extensive reporting capabilities
More informationICP Expert software. Technical Overview. Introduction
ICP Expert software Technical Overview Introduction The Agilent 5110 ICP-OES provides fast sample analysis, using less gas, without compromising on performance for tough samples. It has been designed for
More informationAnalysis of biomolecules by SEC and Ion-Exchange UPLC
Analysis of biomolecules by SEC and Ion-Exchange UPLC Anders Feldthus, Waters Nordic 2011 Waters Corporation 1 Waters Commitment To develop, commercialize and market columns that when used on Waters ACQUITY
More informationNISTmAb characterization with a high-performance RP chromatography column
APPLICATION NOTE 21848 NISTmAb characterization with a high-performance RP chromatography column Author Xin Zhang Thermo Fisher Scientific, Sunnyvale, CA, USA Keywords MAbPac RP column, inter-column reproducibility,
More informationAnalysis of amoxicillin and five impurities on the Agilent 1220 Infinity LC System
Analysis of amoxicillin and five impurities on the Agilent Infinity LC System LC analysis of impurities down to the.% level with long sub--µm columns, high flow rates and back pressure greater than bar
More informationAgilent 1260 Infinity Purification Systems. Infinitely better purity and recovery
Agilent 1260 Infinity Purification Systems Infinitely better purity and recovery 1 Regardless whether you have nanograms or grams of sample Maximize recovery and purity Preparative HPLC has never been
More informationQuantification of genotoxic "Impurity D" in Atenolol by LC/ESI/MS/MS with Agilent 1200 Series RRLC and 6410B Triple Quadrupole LC/MS
Quantification of genotoxic "Impurity D" in Atenolol by LC/ESI/MS/MS with Agilent 12 Series RRLC and 641B Triple Quadrupole LC/MS Application Note Manufacturing Process Development Author Siji Joseph Agilent
More informationGold Standard for recovery and purity
Gold Standard for recovery and purity Agilent 1200 Series Purification Systems Our measure is your success. products applications software services Maximize recovery and purity of your compounds Regardless
More informationEmpower 3 Feature Release 2. New Features. Mr. Jose Wilson Castro Latin America Informatics Director Waters Corporation 1
Empower 3 Feature Release 2 New Features Mr. Jose Wilson Castro Latin America Informatics Director 2016 Waters Corporation 1 Agenda : Empower 3 FR2 Branding Refresh Technology updates Feature Updates o
More informationPersonal Organic Purification
Personal Organic Purification Optimize gradient at any time during run Purify 5 mg - 33 gm without additional hardware Separate compounds using normal or reversed phase chromatography Monitor and control
More informationFlexibility with. Preparative HPLC
Flexibility with Preparative HPLC Date: August 26 th, 2014 Time: 09.00 10.00 am CEST 1 Who are your Presenters? Dr. Christian Textor Product Manager Preparative HPLC Dipl. Biol. Hagen Schlicke Product
More information[ PURIFICATION SOLUTIONS ] Pure at Heart
[ PURIFICATION SOLUTIONS ] Pure at Heart Purification is at the heart of laboratory analysis. It s the foundation of every lab analysis, whether focused on pharmaceutical/ life science, chemical materials,
More informationServices for Regulated Bioanalysis System Solution June 2012
Services for Regulated Bioanalysis System Solution June 2012 2011 Waters Corporation 1 Waters Regulated Bioanalysis System Solution Sample Preparation Solutions Best in class ACQUITY UPLC I-Class The fastest
More informationAnalytical Methods Development and Validation
Understanding and Implementing Efficient Analytical Methods Development and Validation Jay Breaux, Kevin Jones, and Pierre Boulas Analytical methods development and validation play important roles in the
More informationUpdate to USP <621> Chromatography: What does this mean? USP 37 NF 32 1S Current as of August 2014
Update to USP Chromatography: What does this mean? USP 37 NF 32 1S Current as of August 2014 2015 Waters Corporation 1 What is the USP-NF? The United States Pharmacopeia National Formulary (USP-NF)
More information[ ACQUITY UPLC system ] Performance so strong it moved the industry forward
[ ACQUITY UPLC system ] ULTRA PERFORMANCE Performance so strong it moved the industry forward And brought the impact of science beyond the bench The proven performance of the ACQUITY UPLC System, used
More informationEncompassing Method Development, Small Scale Purification, and Post-Purification Analysis with the Investigator SFC System
Encompassing Method Development, Small Scale Purification, and Post-Purification Analysis with the Investigator SFC System Jacquelyn Runco and Rui Chen, Ph.D. Waters Corporation, Milford, MA, USA A P P
More informationValidation Strategies for Equipment from Multiple Vendors
Welcome to our E-Seminar: Validation Strategies for Equipment from Multiple Vendors Page 1 Content FDA guidelines and inspectional observations Validation & Qualification Approaches Instrument Qualification
More informationEmulation of the Agilent 1100 Series LC Through Waters Empower Software Analysis of an Analgesic Mixture
Agilent 129 Infinity II LC with ISET Emulation of the Agilent 11 Series LC Through Waters Empower Software Analysis of an Analgesic Mixture Application Note Small Molecule Pharmaceuticals Author Melanie
More informationApplication Note. Biopharma. Authors. Abstract. James Martosella, Phu Duong Agilent Technologies, Inc Centreville Rd Wilmington, DE 19808
Reversed-Phase Optimization for Ultra Fast Profiling of Intact and Reduced Monoclonal Antibodies using Agilent ZORBAX Rapid Resolution High Definition 3SB-C3 Column Application Note Biopharma Authors James
More informationQbD Concepts Applied to Qualification and Transfer of Analytical Methods
QbD Concepts Applied to Qualification and Transfer of Analytical Methods CMC Strategy Forum Latin America - 2014 Patrick Swann Senior Director Technical Development QbD = Quality by Design QbD - A systematic
More informationAPPLICATION NOTE. UOP : Analysis of Trace CO and CO 2 in bulk H 2 and Light Gaseous Hydrocarbons by GC
UOP 63-13: Analysis of Trace CO and CO 2 in bulk H 2 and Light Gaseous Hydrocarbons by GC Fast Analysis in
More informationLiquid Chromatography Boot Camp Plus For pharmaceutical and Biopharmaceutical industries
2019 Liquid Chromatography Boot Camp Plus For pharmaceutical and Biopharmaceutical industries Features : Solid understanding of LC theory and practice Modern HPLC instrumentation How to develop a method?
More informationAgilent OpenLAB Chromatography Data System IT S TIME TO ACHIEVE MORE
Agilent OpenLAB Chromatography Data System IT S TIME TO ACHIEVE MORE HOW TO DO MORE WITH LESS? Today s laboratories are under pressure to increase productivity and lower costs. These two imperatives apply
More information